Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX)

41 filings reported holding IMRX - Immuneering Corp - Class A Common Stock, $0.001 par value per share as of Q4 2021.
Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12.5M shares of 58.8M outstanding shares and own 21.25% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.19M shares), Cormorant Asset Management, LP (2.3M shares), CITADEL ADVISORS LLC (2.06M shares), BlackRock Inc. (1.72M shares), Rock Springs Capital Management LP (1.09M shares), PERCEPTIVE ADVISORS LLC (681K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (314K shares), VANGUARD GROUP INC (314K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (200K shares), and GEODE CAPITAL MANAGEMENT, LLC (134K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.